Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain

NCT06411067 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Lapse in IRB approval

Conditions

Fibromyalgia

Interventions

DRUG: Erenumab
DRUG: Saline

Sponsor

United States Naval Medical Center, Portsmouth